Background: Sepsis is a global healthcare problem, characterized by whole body inflammation in response to microbial infection, which leads to organ dysfunction. It is a frequent complication in hospitalized patients. Despite the use of available treatment modalities mortality in sepsis remains high, often due to delayed diagnosis and treatment. .Objective: To study the efficacy of procalcitonin as a diagnostic marker for sepsis. Design: This was a cross-sectional study. Methods: Sepsis was confirmed clinically and/or by positive blood culture. Serum PCT was assayed semi-quantitatively by rapid immunochromatographic technique (within 2 hours of sample receipt). The patients were classified into groups. PCT and various other relevant factors were measured in all study subjects. PCT levels of less than 0.1 ng/ml were considered negative; all other levels were considered positive. Data were presented in the form of statistical Tables and charts. SPSS software version 20 was used for statistical analysis. Results: PCT proved to be an excellent indicator of sepsis. Serum PCT levels predicts mortality in the present study. Conclusion: The PCT assay was found to be a useful biomarker of sepsis in this study. The assay could be performed and reported rapidly and provided valuable information before availability of culture results. This might assist in avoiding unwarranted antibiotic usage.
INTRODUCTION
Procalcitonin (PCT) is a peptide precursor of the hormone calcitonin, the latter being involved with calcium homeostasis. PCT is a member of the calcitonin (CT) superfamily of peptides. It is peptide of 116 amino acid with an approximate molecular weight of 14.5 kDa, and its structure can be divided into three sections : amino terminus , immature calcitonin and calcitonin carboxyl-terminus peptide. Under normal physiological conditions, active CT is produced and secreted in the C-cells of the thyroid gland after proteolytic cleavage of PCT, meaning, in a healthy individual, that PCT levels in circulation are very low (<.05 ng/mL). Procalcitonin is part of the inflammatory cascade in sepsis. Procalcitonin levels tend to be elevated in bacterial infections whereas they are depressed in viral infections, and high PCT has been known to predict bacteremia. Procalcitonin is detectable in the serum within 4 hours and has a halflife of 22-26 hours. Peak levels occur between 12 and 48 hours. However, PCT levels may be elevated in patients who do not have sepsis, with levels between 2-10 ng/mL seen in patients with conditions such as autoimmune disorders, trauma, cardiac arrest, surgery, burns and pancreatitis. The present research aims to study the efficacy of procalcitonin as a diagnostic marker for sepsis. Ethical Approval: Approval was taken from the Institutional Ethics Committee prior to commencement of the study. A total of 100 patients with age ranging from 20 to 80 years were undertaken for the study and majority of them belonged to age group of 20 -40 years. SYMPTOMATOLOGY Of all the patients undertaken for study majority were having fever around 96% and 1/3 rd of them showed breathlessness symptoms, around 20% of the patients exhibited symptoms of cough, headache and vomiting and lesser number with burning micturation and pain abdomen. 
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DISCUSSION
The aim of this study was to identify sepsis using serum PCT as a marker in critically ill patients present at the duration of our study in the hospital. Its an uphill task for clinicians in diagnosing infection & sepsis in critically ill patients. Serum PCT has been found to be a very good and to an extent reliable marker of sepsis. During assessment combined role of serum PCT & other clinical signs of inflammation as predictors of sepsis, we found out that the prevalence was much higher in patients over 60 yrs of age. The other studies reported a higher prevalence of sepsis in patients aged 57 years 12 . We found out incidence of sepsis was considerably high in males compared to females in the present study. Fever was the most common symptom in our study followed by breathlessness, cough, burning micturation, headache, vomiting and pain abdomen. We observed in present study Serum PCT has 96% sensitivity. Serum PCT cannot be used as a marker for localized infections or infections having no systemic manifestations. Elevated serum PCT values during rigorous infections may decrease considerably to very low levels with appropriate therapy, It does not always designate complete control of the infection but only that generalization of the infection or the systemic response is under control 14 . Patients after undergoing major trauma or surgery may also have increased serum PCT levels without any clearcut evidence of severe infection. However, the median values under these conditions are usually lesser than those found during severe sepsis and septic shock 4, 15 .
Our study has various outcomes for clinicians. One it definitely indicates that serum PCT as marker is helpful in managing sepsis in critical care. Its used to diagnose sepsis on ICU admission, serum PCT offers a reasonable higher level of precision that other tests. It is very helpful in decision making by physicians and their stepwise approach to the complex management of critically ill patients with sepsis requiring several interventions in a short period of time. The test can be performed within 45 minutes and gives valuable information long before cultural results are available.
CONCLUSIONS
The PCT assay was found to be a useful biomarker of sepsis in this study. The assay could be performed and reported rapidly and provided valuable information before availability of culture results. This might assist in avoiding unwarranted antibiotic usage.
